Evaluation Of Outcomes Following Rotator Cuff Repair Using the REGENETEN Bioinductive Implant

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSmith & Nephew, Inc.

About this trial

This prospective, single-arm, multicenter registry is being conducted to collect real world post-market data from patients who are undergoing rotator cuff repair using the REGENETEN◊ Bioinductive Implant System. The Registry will include up to 50 centers in the United Kingdom (UK), Europe, Australia, and up to 400 patients for the initial evaluation.

Patients will be treated and evaluated according to standard medical care. Outcome data is collected up to 2 years post-surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Subject requires Arthroscopic rotator cuff repair (ARCR);

Patients aged over 18 years old at the time of consent and providing baseline data before undergoing rotator cuff repair surgery (either partial or full thickness tears) will be eligible for this prospective registry.

Disqualifiers

Subject who, in the opinion of the Investigator, has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the registry including mental illness, intellectual disability, and drug or alcohol abuse.

Subjects who do not meet the indication or are contraindicated according to specific Smith+Nephew REGENETEN System's Instructions for Use (IFUs);

Subject that meets the definition of a Vulnerable Subject per ISO14155:2020 Section 3.44.

Trial population

Orthopaedic Clinics/practices

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Arthroscopic rotator cuff repair with REGENETEN Bioinductive Implant augmentation

    Device

    Arthroscopic rotator cuff repair aims at repairing the rotator cuff following tendon tear. The REGENETEN Bioinductive Implant is a medical device intended for the management and protection of tendon injuries. The REGENETEN Bioinductive Implant is indicated for the management and protection of rotator cuff tendon injuries in which there has been no substantial loss of tendon tissue.

Treatment groups

400 Participants
are divided into 1 treatment group
Group A: Rotator cuff repair using REGENETEN1 intervention

Trial outcomes

Primary outcomes

1

EuroQol 5 Dimension 5 Level (EQ-5D-5L) Score

The descriptive system is used to describe the subject's health state \& consists of 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has 5 levels to choose the most appropriate answer: no problems, slight problems, moderate problems, severe problems, and extreme problems. The subject is asked to indicate his/her health state by marking the most appropriate statement in each of the five areas. Responses are coded as single-digit numbers expressing the severity level selected in each dimension. For instance, 'slight problems' (e.g. 'I have slight problems in walking about') is always coded as '2'. The digits for the 5 dimensions are combined in a 5-digit code. The EQ- 5D-5L index value is derived by using the vendor supplied calculator to convert each 5-digit EQ-5D-5L profile. A higher number is a better outcome.

Time frame
Baseline, 6 weeks, 3 months, 6 months, 12 months and 24 months
2

Quick DASH (Disabilities of Arm, Shoulder and Hand) Score

Quick DASH (Disabilities of Arm, Shoulder and Hand) is designed to measure physical function and symptoms. It assesses 11 items, with scores ranging from 0 to 100 where 0 indicates no disability (i.e., better outcome) and 100 indicates most severe disability (i.e., worse outcome).

Time frame
Baseline, 6 weeks, 3 months, 6 months, 12 months and 24 months
3

Oxford Shoulder Score (OSS)

The Oxford Shoulder Score (OSS) is a questionnaire for the assessment of outcomes of shoulder surgery, which can reduce the observer's errors in the evaluation. It contains 12- item patient-reported outcome (PRO) measures specifically designed and developed for assessing outcomes of shoulder surgery such as assessing the impact on patients' quality of life of degenerative conditions (e.g., arthritis and rotator cuff problems). The OSS consists of 12 questions each scored 0 to 4 (0=unbearable, 1=severe, 2=moderate, 3=mild, 4=none) with 4 representing the best outcome. When the 12 items are summed, this produces overall scores that run from 0 to 48, with zero (0) representing a severe shoulder problem and 48 representing no related problem. Higher scores represent better clinical outcomes.

Time frame
Baseline, 6 weeks, 3 months, 6 months, 12 months and 24 months
4

Pain, Visual Analog Scale (VAS) Score

Pain is assessed on a 100-point scale ranging from 0 to 100, with zero (0) representing no pain and 100 representing the worst pain imaginable

Time frame
Baseline, 2 weeks, 6 weeks, 3 months, 6 months, 12 months and 24 months

Secondary outcomes

1

Retear Rate

Cumulative 3 months, 6 months, 12 months, and 24 months retear rate. Failure is defined as Sugaya Type IV or V retear/recurrence (full-thickness discontinuity seen on both coronal and oblique sagittal MRI images).

Time frame
3 months, 6 months, 12 months, and 24 months
2

Post-operative Recovery: Sling Type and Mobilization Time

The type of sling will be collected and presented for each treatment arm summarizing if standard sling, shoulder immobilizer, abduction sling, ER sling, or other were advised. Mobilization time will be calculated for both arms.

Time frame
2 weeks
3

Post-operative Recovery: Return to Work

Return to work questionnaires are collected at baseline and at 6 months post-op. At baseline, information on working arrangements are established: * Occupation status: Full time/part time/ retired * Occupation type: Sedentary/labor intensive * Impact of their diagnosis on their work performance: negative impact/no change At 6 months, information on changes to working arrangements is established: * Changes to occupation status * Returned to work and at what level: not returned due to procedure, not returned for other reasons, retired, lower level, same level, higher level * Time taken to return to work in days/weeks/months (if applicable)

Time frame
Baseline and 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.